Os Estudos mais importantes de 2023: CAPItello-291
Apr 24 2024
Length: 30 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Os Estudos mais importantes de 2023: CAPItello-291

Listen for free

View show details

Summary
No nosso episódio inaugural, discutiremos o estudo CAPItello-291 que avaliou a adição de capivasertib à fulvestranto no câncer de mama receptor hormonal -positivo metastático. Acompanhem o episódio em que o Dr. Romualdo Barroso e Dra. Débora Glagiato discutem o estudo de maneira aprofundada, mas com atenção a aspectos da prática clínica, importantes para a comunidade médica e acadêmica.

Show more Show less

Physical Illness & Disease Hygiene & Healthy Living

Show more Show less

What listeners say about Os Estudos mais importantes de 2023: CAPItello-291

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon